Phase II study of temozolomide monotherapy in patients with extrapulmonary neuroendocrine carcinoma

Extrapulmonary neuroendocrine carcinoma (EPNEC) is a lethal disease with a poor prognosis. Platinum‐based chemotherapy is used as the standard first‐line treatment for unresectable EPNEC. Several retrospective studies have reported the results of the utilization of temozolomide (TMZ) as a drug for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Noritoshi, Takeda, Yuma, Okubo, Naoki, Suzuki, Akihiro, Tokuhisa, Motohiko, Hiroshima, Yukihiko, Ichikawa, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088944/
https://www.ncbi.nlm.nih.gov/pubmed/33453146
http://dx.doi.org/10.1111/cas.14811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088944/
https://www.ncbi.nlm.nih.gov/pubmed/33453146
http://dx.doi.org/10.1111/cas.14811

Ejemplares similares